MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to ...

Astex Pharmaceuticals, and MSD (Merck), have revealed a worldwide research collaboration, intending to identify small molecule candidates with activity towards a tumor suppressor protein for the ...

The biopharmaceutical company lycera has announced a collaboration agreement with Merck, Sharpe & Dohme (MSD) that will focus on developing and commercializing small-molecule therapies for treating a ...

The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. MSD, known as Merck in the US and Canada, ...